Reaktionsgleichung
[C:1]([C:5]1[N:10]=[C:9]([O:11][CH2:12][CH3:13])[C:8]([C:14]2[N:15]([C:35](Cl)=[O:36])[C:16]([C:28]3[CH:33]=[CH:32][C:31]([Cl:34])=[CH:30][CH:29]=3)([CH3:27])[C:17]([C:20]3[CH:25]=[CH:24][C:23]([Cl:26])=[CH:22][CH:21]=3)([CH3:19])[N:18]=2)=[CH:7][N:6]=1)([CH3:4])([CH3:3])[CH3:2].[C:38]([NH:42][C:43](=[O:51])[CH2:44][N:45]1[CH2:50][CH2:49][NH:48][CH2:47][CH2:46]1)([CH3:41])([CH3:40])[CH3:39]>>[C:38]([NH:42][C:43](=[O:51])[CH2:44][N:45]1[CH2:46][CH2:47][N:48]([C:35]([N:15]2[C@@:16]([C:28]3[CH:29]=[CH:30][C:31]([Cl:34])=[CH:32][CH:33]=3)([CH3:27])[C@@:17]([C:20]3[CH:25]=[CH:24][C:23]([Cl:26])=[CH:22][CH:21]=3)([CH3:19])[N:18]=[C:14]2[C:8]2[C:9]([O:11][CH2:12][CH3:13])=[N:10][C:5]([C:1]([CH3:3])([CH3:4])[CH3:2])=[N:6][CH:7]=2)=[O:36])[CH2:49][CH2:50]1)([CH3:41])([CH3:39])[CH3:40]Komponenten
3
Edukt 2
Produkt 1
Versuchsvorschrift
In a manner analogous to the method described in example 3, rac-(4S*,5R*)-2-(2-tert-butyl-4-ethoxy-pyrimidin-5-yl)-4,5-bis-(4-chloro-phenyl)-4,5-dimethyl-4,5-dihydro-imidazole-1-carbonyl chloride was reacted with N-tert-butyl-2-piperazin-1-yl-acetamide (Enamine-BB) to give the title compound. HR-MS (ES, m/z) calculated for C38H50N7O3Cl2 [(M+H)+] 722.3347, observed 722.3341.
Quellen und Nachweise
- ORD-Eintrag
- ord-d344ca844f0d4e8b94c55a1ff7a15c6a
- Quelldatensatz
- uspto-grants-2013_08
- Patentnummer
- US08513239B2
Verknüpfte Notizen
Wird geladen…